Guerbet S.A. Actions Port. EO 1
- BID
8.55
- ASK
9.35
- 2,339 Units2,139 Units
- 07/22, 21:59:01 PM
Sector and Industry
Healthcare, Healthcare Equipment
Performance (1Y)
59.72%
Market Cap
-
P/E Ratio
0.00
Dividend Yield
0.00 %
Earnings per Share
-8.59 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Abbott Laboratories | 185.26 Bil. | 39.29 Bil. | 33.69 | -53.32 % | 0.00 | - |
| Intuitive Surgical Inc | 171.24 Bil. | 8.92 Bil. | 71.93 | +17.90 % | 0.00 | - |
| Boston Scientific Corp | 120.40 Bil. | 17.79 Bil. | 49.17 | +49.88 % | 0.00 | - |
| Stryker Corp. | 114.47 Bil. | 22.26 Bil. | 41.85 | +3.99 % | 0.00 | - |
| Medtronic PLC | 90.93 Bil. | 31.27 Bil. | 22.35 | -4.61 % | 0.00 | - |
| Siemens Healthineers AG | 51.40 Bil. | 23.38 Bil. | 24.04 | +10.40 % | 0.00 | - |
| Hoya Corp | 48.59 Bil. | 5.43 Bil. | 35.69 | +17.33 % | 0.00 | - |
| Becton Dickinson and Co. | 45.46 Bil. | 19.79 Bil. | 32.18 | -3.33 % | 0.00 | - |
| Edwards Lifesciences Corp | 42.15 Bil. | 5.38 Bil. | 47.11 | -27.44 % | 0.00 | - |
| Alcon AG | 33.20 Bil. | 9.24 Bil. | 38.41 | -7.56 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 8.56 G | 0 Units |
| PRICE DETERMINATION TIME | 07/22/2026 / 09:56:53 PM | |
| DAILY VOLUME (UNITS) | 3 | |
| DAILY HIGH / LOW | 9.04 | 8.4 |
| PREV. DAY'S PRICE | 8.52 | (07/21) |
| CHANGE DAY BEFORE | +0.04 | 0.47 % |
| 52 WEEK HIGH / LOW | 22.85 (07/24) | 7.88 (03/17) |
Key Figures (in EUR)
| 2023 | 2024 | 2025 | 2026e | 2027e | |
|---|---|---|---|---|---|
EARNINGS PER SHARE | 1.90 | 1.28 | -8.59 | 1.51 | 2.21 |
DIVIDENDS PER SHARE | 0.50 | 0.00 | 0.00 | 0.00 | 0.20 |
DIVIDEND YIELD IN % | 2.56 % | 0.00 % | 0.00 % | - | - |
DIVIDEND GROWTH IN % | 0.00 % | -100.00 % | - | - | - |
PRICE - EARNINGS RATIO | 10.28 | 21.00 | - | 5.86 | 4.00 |
PRICE - BOOK RATIO | 0.65 | 0.86 | 0.68 | - | - |
PRICE - SALES RATIO | 0.31 | 0.40 | 0.23 | - | - |
PRICE - CASH FLOW RATIO | 14.59 | 5.56 | 2.94 | - | - |
Master Data
| WKN | 870481 |
| ISIN | FR0000032526 |
| SYMBOL | 4G8 |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | GUERBET |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | - |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Healthcare Equipment |
| NUMBER OF SHARES | - |
| MARKET CAPITALISATION | - |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | 1.90 % | -1.04 % | -8.74 % | -36.02 % | -59.72 % | -52.34 % | -69.91 % | -39.63 % |
| HIGH | 9.27 | 9.62 | 12.40 | 14.20 | 22.85 | 39.55 | 44.55 | 15.02 |
| LOW | 8.26 | 8.09 | 8.09 | 7.88 | 7.88 | 7.88 | 7.88 | 7.88 |
Dividende
pro Aktie
Company profile
Guerbet SA engages in the research, development, manufacture, and sale of contrast products for medical imaging. The company operates through the following segments: Diagnostic Imaging and Interventional Imaging. The Diagnostic Imaging segment includes MRI and X-Ray contrast media. The Interventional Imaging covers any invasive medical procedure whose purpose is to diagnose and treat a disease. The company was founded by André Guerbet in 1926 and is headquartered in Paris, France.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.